7,183 Followers on Owler

Biogen

is a Massachusetts-based biotechnology company that researches and develops novel therapies for the treatment of neurological diseases across the globe... Read more
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Biogen

is a Massachusetts-based biotechnology company that researches and develops novel therapies for the treatment of neurological diseases across the globe... Read more
Biogen President & CEO: Christopher A. Viehbacher

President & CEO

Christopher A. Viehbacher

CEO Approval Rating

48/100

1978

PublicNASDAQBIIB

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$9.9B
Employees
8,720
Funding
$250M
Acquisitions
6
Investments
11

News

Partnership
Nov 26, 2025
Pharmabiz
Biogen, Dayra Therapeutics ink collaboration to discover and develop oral macrocyclic peptides for immunological conditions
Acquisition
Sep 18, 2025
FinanzNachrichten
Biogen acquired Alcyone Therapeutics, Inc. for $85M

Biogen Competitors

1Sanofi
2Bayer
3Teva
4Novartis
5Genentech
6Roche
7Pfizer
8GSK
9AstraZeneca
10Bristol-Myers Squibb
Unlock 21 + competitors

Trending Companies